AU2002247813A1 - Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells - Google Patents

Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells

Info

Publication number
AU2002247813A1
AU2002247813A1 AU2002247813A AU2002247813A AU2002247813A1 AU 2002247813 A1 AU2002247813 A1 AU 2002247813A1 AU 2002247813 A AU2002247813 A AU 2002247813A AU 2002247813 A AU2002247813 A AU 2002247813A AU 2002247813 A1 AU2002247813 A1 AU 2002247813A1
Authority
AU
Australia
Prior art keywords
maturation
gram
inducing
dendritic cells
membrane fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002247813A
Other versions
AU2002247813B2 (en
Inventor
Jean-Yves Bonnefoy
Pascale Jeannin
Christine Libon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0103518A external-priority patent/FR2822071B1/en
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU2002247813A1 publication Critical patent/AU2002247813A1/en
Application granted granted Critical
Publication of AU2002247813B2 publication Critical patent/AU2002247813B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002247813A 2001-03-15 2002-03-14 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells Ceased AU2002247813B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0103518A FR2822071B1 (en) 2001-03-15 2001-03-15 USE OF A MEMBRANE FRACTION OF GRAM NEGATIVE BACTERIA TO INDUCE THE MATURATION OF DENDRITIC CELLS
FR01/3518 2001-03-15
PCT/FR2002/000906 WO2002074939A1 (en) 2001-03-15 2002-03-14 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells

Publications (2)

Publication Number Publication Date
AU2002247813A1 true AU2002247813A1 (en) 2003-03-27
AU2002247813B2 AU2002247813B2 (en) 2007-06-28

Family

ID=8861155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002247813A Ceased AU2002247813B2 (en) 2001-03-15 2002-03-14 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells

Country Status (7)

Country Link
US (1) US20050070463A1 (en)
EP (1) EP1368457A1 (en)
JP (1) JP2004531496A (en)
AU (1) AU2002247813B2 (en)
CA (1) CA2460779A1 (en)
FR (1) FR2822071B1 (en)
WO (1) WO2002074939A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252996B2 (en) 2001-01-15 2007-08-07 I.D.M. Immuno-Designed Molecules Ancillary composition for the preparation of committed mature dentritic cells
EP1617867B1 (en) * 2003-04-30 2011-10-26 Medi Service S.R.L. Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
US8034359B2 (en) * 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
DK176322B1 (en) * 2004-09-21 2007-08-06 Broendum V As Detention device for seating and berths in buses
JP5693010B2 (en) 2007-03-05 2015-04-01 オーエム ファーマＯｍ Ｐｈａｒｍａ Bacterial extract for respiratory disorders and method for producing the same
BRPI0817404A2 (en) * 2007-11-13 2018-06-12 Du Pont "garment"
CA2804709A1 (en) 2010-07-26 2012-02-02 Qu Biologics Inc. Immunogenic anti-inflammatory compositions
EP2662441A1 (en) * 2012-05-12 2013-11-13 Universiteit Maastricht Method for the in vitro maturation of dendritic cells
CN113855791A (en) 2014-05-02 2021-12-31 Qu生物制药公司 Antimicrobial immunomodulation
WO2020069211A1 (en) * 2018-09-27 2020-04-02 Decoy Biosystems, Inc. Methods of treatment of infections using bacteria
WO2020172492A2 (en) * 2019-02-22 2020-08-27 Evelo Biosciences, Inc. Bacterial membrane preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2785542B1 (en) * 1998-11-06 2001-02-09 Pf Medicament USE OF AN ENTEROMACTERY OmpA PROTEIN FOR THE SPECIFIC TARGETING OF A BIOLOGICALLY ACTIVE SUBSTANCE THAT IS ASSOCIATED WITH CELLS PRESENTING ANTIGENS SUCH AS HUMAN DENDRITIC CELLS
FR2790960B1 (en) * 1999-03-15 2002-10-31 Pf Medicament USE OF BACTERIAL MEMBRANE FRACTIONS WITH IMMUNOSTIMULANT ACTIVITY IN THE TREATMENT OF CANCERS, THEIR PREPARATION METHODS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2790959B1 (en) * 1999-03-15 2003-06-27 Pf Medicament USE OF BACTERIAL MEMBRANARY FRACTIONS WITH ADJUVANT EFFECT, THEIR PREPARATION METHODS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2819263B1 (en) * 2001-01-10 2003-04-11 Lco Sante PROCESS FOR MATURATION OF DENDRITIC CELLS AND ACTIVATION OF MACROPHAGES WITH RU 41740

Similar Documents

Publication Publication Date Title
AU2001264147A1 (en) Drive system
AU2001295316A1 (en) Electric wheelchair drive system
AU2002327608A1 (en) Airway device
AUPR798001A0 (en) Adjustable wheelchair
AU2002327490A1 (en) Membrane probing system
AU2002247813A1 (en) Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
AU2002234235A1 (en) Sectional drive system
AU2002311791A1 (en) Secretory molecules
AU2002358214A1 (en) Membrane
AU2001285693A1 (en) Bio-reactor
AU2002322010A1 (en) Methods for regulating bacteria
AU2002257064A1 (en) Methods for isolating proteins expressed by dendritic cells
WO2002073485A1 (en) System for providing medical service
AU2001284630A1 (en) Drive system
AU2001256410A1 (en) Drive device for wheelchair
AU2002363761A1 (en) Porus materials based on template-forming microorganisms
AU2002355993A1 (en) Resuscitation of not immediately culturable bacteria
AU2003218007A1 (en) Methods for purifying selected cea family member proteins
AU2002326011A1 (en) Dialysis apparatus
AU2002344252A1 (en) Mammalian diabetes-mediating proteins
AU2001226965A1 (en) Drive system
AU2001253101A1 (en) Haplotypes of the scn2b gene
AU2002233664A1 (en) Naphthyridine derivative
AU2001264800A1 (en) Haplotypes of the aldh5a1 gene
AU2002253453A1 (en) Multipotent o-2a progenitors from the neurohypophysis